Mucormycosis is a life-threatening disease, were rhinocerebral infection is most commonly seen in the clinical setting. Chronic mucormycosis is a rare presentation that exhibits a challenging diagnosis. We describe the case of a 47 year old diabetic man with complains of left zygomatic arch swelling of 3 months evolution. He had received previous antibiotic treatment without improvement. Biopsy of maxillary sinus revealed the presence of non-septated, 90° angle branched hyphae compatible with zygomicetes. The patient was treated with surgical debridement and amphotericin B until there was no evidence of fungi in the tissue by biopsy. We reviewed chronic rhino-orbito-cerebral mucormycosis from 1964–2014 and 22 cases were found, being this the second case of chronic mucormycosis reported in Mexico. A quarter of the cases were seen in immunocompetent hosts. As only 20% of the causal agent can be isolated by culture, the diagnosis is mainly made by biopsy. Besides treatment with amphotericin B, posaconazole as alternative, and control of the underlying comorbidities, surgical debridement represents the corner stone therapy. We recommend at least 36 month follow-up, due to the 13% risk of recurrence. A chronic presentation has a general survival rate of approximately 83%.
We demonstrate the morphological variability that exists in this region. Gender differences that must be considered by the surgeon to avoid complications. Further studies are needed to evaluate the value of these findings when predicting surgical complications. A CT before PNS surgery is already widely accepted.
Introduction:A high riding jugular bulb is the most common anatomical variation of the petrous section of the temporal bone. The objective of our study was to determine the prevalence of dehiscence and high riding jugular bulb (HRJB) in a Mexican population. Material and methods: This is an observational retrospective, cross-sectional, and descriptive study. The presence of High Riding Jugular Bulb was analyzed, taking as reference the basal turn of the cochlea in axial sections and then reformatted in coronal sections to observe the presence or absence of dehiscence. Patients between 0 to 95 years of age were included and classified by age groups for analysis. Infants included patients ≤ 2 years old, children from 3 to 12, teenagers from 13 to 18, and adults included patients >18 years of age. Results: A total of 229 CT (458 ears) were included. The prevalence of HRJB was 38.4%, higher in women (44.6%), and present bilaterally in 7.9% of patients. It is the highest prevalence reported in the literature. Dehiscence was present in 1.3% of the population. Conclusion: High Riding Jugular Bulb and its dehiscence are important anatomical variations associated with several symptoms like unexplained headache and tinnitus. Due to unawareness of these variations in surgery, the lesion to a vessel could be fatal. It is otorhinolaryngologists be aware of the high prevalence for patient safety.
Angiosarcomas are malignant neoplasias of rapid growth that develop from endothelial cells. They represent 2% of all sarcomas and only 1–4% are located in the aerodigestive tract. Since 1977, only 16 cases have been reported.We present a 33-year-old male with spontaneous epistaxis that was refractory to cauterization. During physical examination, a smooth purplish tumor of 1.5 cm × 1.5 cm was identified. A CT scan showed a nonenhanced tumor in the left nostril on the uncinate process. A biopsy revealed an intermediate-grade angiosarcoma. Surgical removal followed by radiation therapy was performed with good result. Aerodigestive angiosarcomas have a better prognosis than angiosarcomas of other locations due to better cell differentiation and the presence of early symptoms. Recurrence can occur because of tumor tissue left during resection. Our patient continues tumor free after three years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.